Close Menu

NEW YORK (GenomeWeb) – Phase Genomics said today that it has received a two-year, $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) to develop an affordable, high-throughput Hi-C kit and computational analysis platform for microbiome research and discovery.

The firm said it had previously received a Phase I SBIR grant from the NIAID as well as an investment from WRF Capital and Congruent Ventures to develop the platform.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.

Aug
22
Sponsored by
BC Platforms

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.

Aug
28
Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.